Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment

S. W. Lewis; L. Davies; P. B. Jones; T. R.E. Barnes; R. M. Murray; R. Kerwin; D. Taylor; K. P. Hayhurst; A. Markwick; H. Lloyd; G. Dunn

doi:10.3310/hta10170

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment

S. W. Lewis^*
, L. Davies
, P. B. Jones
, T. R.E. Barnes
, R. M. Murray
, R. Kerwin
, D. Taylor
, K. P. Hayhurst
, A. Markwick
, H. Lloyd
, G. Dunn

^*Corresponding author for this work

School of Psychology

Wythenshawe Hospital
Manchester Royal Infirmary
University of Cambridge
University of London
King's College London
Department of Human Services, Victoria
University of Oxford
University of Manchester

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	0
Journal	Health Technology Assessment
Volume	10
Issue number	17
DOIs	https://doi.org/10.3310/hta10170
Publication status	E-pub ahead of print - May 2006

Access to Document

10.3310/hta10170

Cite this

Lewis, S. W., Davies, L., Jones, P. B., Barnes, T. R. E., Murray, R. M., Kerwin, R., Taylor, D., Hayhurst, K. P., Markwick, A., Lloyd, H., & Dunn, G. (2006). Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Health Technology Assessment, 10(17). Advance online publication. https://doi.org/10.3310/hta10170

@article{c082db4d1de24b08957d5c6991b242ef,

title = "Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment",

author = "Lewis, \{S. W.\} and L. Davies and Jones, \{P. B.\} and Barnes, \{T. R.E.\} and Murray, \{R. M.\} and R. Kerwin and D. Taylor and Hayhurst, \{K. P.\} and A. Markwick and H. Lloyd and G. Dunn",

year = "2006",

month = may,

doi = "10.3310/hta10170",

language = "English",

volume = "10",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Journals Library",

number = "17",

}

Lewis, SW, Davies, L, Jones, PB, Barnes, TRE, Murray, RM, Kerwin, R, Taylor, D, Hayhurst, KP, Markwick, A, Lloyd, H & Dunn, G 2006, 'Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment', Health Technology Assessment, vol. 10, no. 17. https://doi.org/10.3310/hta10170

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. / Lewis, S. W.; Davies, L.; Jones, P. B. et al.
In: Health Technology Assessment, Vol. 10, No. 17, 05.2006.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment

AU - Lewis, S. W.

AU - Davies, L.

AU - Jones, P. B.

AU - Barnes, T. R.E.

AU - Murray, R. M.

AU - Kerwin, R.

AU - Taylor, D.

AU - Hayhurst, K. P.

AU - Markwick, A.

AU - Lloyd, H.

AU - Dunn, G.

PY - 2006/5

Y1 - 2006/5

U2 - 10.3310/hta10170

DO - 10.3310/hta10170

M3 - Article

SN - 1366-5278

VL - 10

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 17

ER -

Lewis SW, Davies L, Jones PB, Barnes TRE, Murray RM, Kerwin R et al. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Health Technology Assessment. 2006 May;10(17). Epub 2006 May. doi: 10.3310/hta10170